NCT00100230View on ClinicalTrials.gov

DHA and X-Linked Retinitis Pigmentosa

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2014

Conditions
Retinitis PigmentosaX-linked Genetic Diseases
Interventions
DRUG

docosahexaenoic acid OR corn/soy oil placebo

daily intake of DHA based on body weight or corn/soy oil placebo(oil not containing DHA; 4 year trial

Trial Locations (1)

75231

Retina Foundation of the Southwest, Dallas

All Listed Sponsors
collaborator

Foundation Fighting Blindness

OTHER

collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

Retina Foundation of the Southwest

OTHER

NCT00100230 - DHA and X-Linked Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter